In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Etoposide Teva Drug Master File in Korea (Etoposide Teva KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Etoposide Teva. The MFDS reviews the Etoposide Teva KDMF as part of the drug registration process and uses the information provided in the Etoposide Teva KDMF to evaluate the safety and efficacy of the drug.
After submitting a Etoposide Teva KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Etoposide Teva API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Etoposide Teva suppliers with KDMF on PharmaCompass.